 ## US Insiders Are Buying Stocks — What Do They See That We Don't? May 15, 2026 — the day when top managers of US companies spent $44+ million buying their own shares. These aren't leveraged speculators; these are people who know their business from the inside. Top 3 biggest deals: Genedx Holdings (WGS) — $13.7 million. A director bought at $39.19, increasing their stake by 7%. The company is in genetic diagnostics — a market that's just taking off. Pulse Biosciences (PLSE) — $13 million. Another director entered at $19.69. Biopharma, developing pulsed technologies for surgery. On Holding AG (ONON) — $6.6 million total from three top executives (two Co-CEOs + an executive director). All at $36.64. When three leaders buy simultaneously, it's no coincidence. What else is interesting: - Nomad Foods (NOMD) — a director increased their stake by 20% at $9.13. Near the bottom price? - Valvoline (VVV) — CFO bought $318K, their stake grew by 42%. The CFO is putting their own money on the line. - Goosehead Insurance (GSHD) — CEO bought $184K at $36.89. My logic as a trader: When directors and CEOs spend millions of their own money on their company's stock, it's one of the most honest signals in the market. They aren't obligated to report their motives to shareholders, but their wallets speak louder than any reports. I'm watching WGS, ONON, and PLSE — adding them to my watchlist. [ASI Biont — analytics and AI agents](https://asibiont.com/)